Document is current
Any future updates will be listed below
-
Authors
Brêchet, Arthur
Kohler, Philipp
Dörr, Tamara
Grässli, Fabian
Vock, Michael
Salát, Jiří
Růžek, Daniel
Friedl, Andrée
Vuichard-Gysin, Danielle
Croxatto, Antony
Lienhard, Reto
Ackermann-Gäumann, Rahel
-
Funding
Funding for this research was provided by:
Swiss National Sciences Foundation (PZ00P3_179919)
Ministerstvo Zdravotnictví Ceské Republiky (NU21-05-00143, NU21-05-00143)
- License Information
-
More Information
Article History
Received: 9 November 2024
Accepted: 28 February 2025
First Online: 11 March 2025
Declarations
:
: RA-G reports honoraria for lectures and/or research grants from Pfizer and Bavarian Nordic, which do, however, not relate to the present work. RL reports honoraria for presentations and discussions on the impact and prevention of different tick-borne diseases and the epidemiology of Lyme disease, which do also not relate to the present work. The other authors report no conflicting interests.
: The study was approved by the ethics committee of Eastern Switzerland (#2020–00502). All study data were pseudonymized and REDCap was used for data collection. REDCap is a secure and established web application for clinical studies, compliant with the International Council on Harmonization of Good Clinical Practice (ICH-GCP).
: Not applicable.
